Grew product P&L from $41MM to $670MM in revenue by developing and selling 7 new medical/surgical service lines into health plans and systems. Increased from 17MM total covered lives with one product to 25MM total covered lives, >75% of covered lives having 2 or more products. Led the behavioral health portfolio, growing revenue from $454M to $554M by expanding into autism services and launching digital cognitive behavioral health tools, driving market adoption and patient e

Led global finance for a $4B business unit, driving double-digit revenue growth, increasing operating earnings 30%, and achieving record margins through refined investment strategies, expense management, and operational scaling. Provided strategic financial leadership to clients across industries, enabling data-driven decisions that supported $100M+ in growth, investment optimization, and market expansion initiatives. Transformed financial operations for an early-stage pharma

Positioned high-profile pharmaceutical companies to outpace competitors through complex, transformative change initiatives, closing profitability gaps from –16% to +20% across Fortune 100 divisions and delivering $42M in EBITDA gains within five years. Responsible for building a medical portfolio from the ground up, including the acquisition of 40 healthcare practices, surgical centers, and multiple billing and EMR organizations. Oversaw the successful transition of six CEOs

Led post-merger integration of acquired entities, including consolidation of financial operations. Established optimized banking and investment structures projected to generate additional interest income. Managed monthly compensation and payment processes for a large network of contracted physicians and leased facilities across multiple locations. As Interim CFO, converted financials from cash to accrual, established a corporate card program generating over $500K in funding,

Lead global marketing strategy to strengthen brand presence, drive market expansion, and accelerate growth across a diverse portfolio of plasmid DNA, mRNA, proteins, and other key components supporting gene and cell therapy, vaccines, and diagnostics. Partner with commercial, product, and R&D teams to deliver customer-focused campaigns, elevate thought leadership, and advance a data-driven marketing transformation that enables groundbreaking science and team excellence Execut

Built the FP&A function from the ground up, reporting directly to the CFO, creating financial models for budgeting, forecasting, scenario planning, and new product ventures, while managing direct reports. Developed and implemented a 13-week cash flow model and integrated SaaS revenue model combining three legacy businesses to improve forecasting accuracy and financial visibility. Implemented Jirav FP&A software integrated with NetSuite, creating monthly reporting packages, da

PE EXECUTIVE COMPENSATION Q3 2025

The Tolan Group (TTG), a Hunt Scanlon Top 50 Healthcare Executive Search Firm, is pleased to announce the successful placement of Marlah Bonner as Senior Vice President of Advancement and Executive Director of the Elwyn Health and Human Services Foundation at Elwyn. She brings over 20 years of experience in major and principal gifts, including more than a decade leading nonprofit fundraising, advancement, and capital campaigns. Elwyn, founded in 1852 and headquartered in Medi